{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:31:55Z","timestamp":1767828715724,"version":"3.49.0"},"publisher-location":"Berlin, Heidelberg","reference-count":170,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540689607","type":"print"},{"value":"9783540689645","type":"electronic"}],"license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-68964-5_22","type":"book-chapter","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T21:48:50Z","timestamp":1229464130000},"page":"507-531","source":"Crossref","is-referenced-by-count":11,"title":["Erectile Dysfunction and Lower Urinary Tract"],"prefix":"10.1007","author":[{"given":"Peter","family":"Sandner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Neuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"22_CR1_22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/bmj.308.6934.929","volume":"308","author":"P Abrams","year":"1994","unstructured":"Abrams P (1994) New words for old: lower urinary tract symptoms for prostatism. Br Med J 308:929\u2013930","journal-title":"Br Med J"},{"key":"22_CR2_22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, et al (2002) The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the internation continence society. Neurourol Urodyn 21:167\u2013178","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"22_CR3_22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pros.10077","volume":"51","author":"PI Adolfsson","year":"2002","unstructured":"Adolfsson PI, Ahlstrand C, Varenhorst E, et al (2002) Lysophosphatidic acid stimulates prolifera tion of cultured smooth muscle cells from human BPH tissue: sildenafil and papaverin generate inhibition. Prostate 51(1):50\u201358","journal-title":"Prostate"},{"key":"22_CR4_22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0022-5347(05)00341-1","volume":"175","author":"SE Althof","year":"2006","unstructured":"Althof SE (2006) Prevalence, characteristics and implication of premature ejaculation\/rapid ejacu lation. J Urol 175:842\u2013848","journal-title":"J Urol"},{"issue":"2","key":"22_CR5_22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/00926230590909989","volume":"31","author":"SE Althof","year":"2005","unstructured":"Althof SE, Rosen RC, DeRogatis L, et al (2005) Outcome measurement in female sexual dysfunc tion clinical trials: review and recommendations. J Sex Marital Ther 31(2):153\u2013166","journal-title":"J Sex Marital Ther"},{"key":"22_CR6_22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/physrev.00038.2003","volume":"84","author":"KE Andersson","year":"2004","unstructured":"Andersson KE, Arner A (2004) Urinary bladder contraction and relaxation: physiology andpPatho-physiology. Physiol Rev 84:935\u2013986","journal-title":"Physiol Rev"},{"key":"22_CR7_22","first-page":"773","volume":"50","author":"C Aschka","year":"2001","unstructured":"Aschka C, Himmel W, Ittner E, et al (2001) Sexual problems of male patients in family practice. J Fam Pract 50:773\u2013778","journal-title":"J Fam Pract"},{"key":"22_CR8_22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1464-410x.1999.00142.x","volume":"84","author":"IA Ayta","year":"1999","unstructured":"Ayta IA, McKinlay JB, Krane RJ (1999) The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 84:50\u201356","journal-title":"BJU Int"},{"issue":"2","key":"22_CR9_22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/01.ju.0000064923.29954.7e","volume":"170","author":"KM Azadzoi","year":"2003","unstructured":"Azadzoi KM, Babayan RK, Kozlowski R, et al (2003) Chronic ischemia increases prostatic smooth muscle contraction in the rabbit. J Urol 170(2):659\u2013663","journal-title":"J Urol"},{"issue":"2","key":"22_CR10_22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2003.08.012","volume":"477","author":"JS Baracat","year":"2003","unstructured":"Baracat JS, Teixeira CE, Okuyama CE, et al (2003) Relaxing effects induced by the soluble guany lyl cyclase stimulator BAY 41\u20132272 in human and rabbit corpus cavernosum. Eur J Pharmacol 477(2):163\u2013169","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"22_CR11_22","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1471-0528.2003.02438.x","volume":"110","author":"R Basson","year":"2003","unstructured":"Basson R, Brotto LA (2003) Sexual psychophysiology and effects of sildenafil citrate in oestro genised women with acquired genital arousal disorder and impaired orgasm: a randomized controlled trial. BJOG 110(11):1014\u20131024","journal-title":"BJOG"},{"issue":"4","key":"22_CR12_22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/152460902317586001","volume":"11","author":"R Basson","year":"2002","unstructured":"Basson R, McInnes R, Smith MD, et al (2002) Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med 11(4):367\u2013377","journal-title":"J Womens Health Gend Based Med"},{"issue":"suppl","key":"22_CR13_22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0022-5347(18)30672-4","volume":"177","author":"C Beamon","year":"2007","unstructured":"Beamon C, Salkini M, Mazur C, et al (2007) The effect of sildenafil citrate on bladder outlet obstruction in a mouse model. J Urol 177(suppl):140","journal-title":"J Urol"},{"issue":"3","key":"22_CR14_22","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0022-5347(01)62833-7","volume":"160","author":"AJ Becker","year":"1998","unstructured":"Becker AJ, Stief CG, Meyer M, et al (1998) The effect of the specific phosphodiesterase-IV-inhibitor rolipram on the ureteral peristalsis of the rabbit in vitro and in vivo. J Urol 160(3): 920\u2013925","journal-title":"J Urol"},{"issue":"3","key":"22_CR15_22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1569-9056(08)60765-4","volume":"7","author":"D Behr-Roussel","year":"2008","unstructured":"Behr-Roussel D, Oger S, Tinel H, et al (2008) PDE5 gene expression and relaxant effects of var denafil in male and female human and rat detrusor muscle. Eur Urol 7(3):263","journal-title":"Eur Urol"},{"issue":"2","key":"22_CR16_22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00345-002-0281-4","volume":"20","author":"JR Berman","year":"2002","unstructured":"Berman JR, Bassuk J (2002) Physiology and pathophysiology of female sexual function and dys function. World J Urol 20(2):111\u2013118","journal-title":"World J Urol"},{"key":"22_CR17_22","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1097\/01.ju.0000090966.74607.34","volume":"170","author":"JR Berman","year":"2003","unstructured":"Berman JR, Berman LA, Toler SM, et al (2003) Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. J Urol 170:2333\u20132338","journal-title":"J Urol"},{"key":"22_CR18_22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0031-9384(95)02272-4","volume":"60","author":"M Bialy","year":"1996","unstructured":"Bialy M, Beck J, Abramczyk P, Treszebski A, et al (1996) Sexual behaviour in male rats after nitric oxide synthase inhibition. Physiol Behav 60:139\u2013143","journal-title":"Physiol Behav"},{"key":"22_CR19_22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.ijir.3900703","volume":"13","author":"E Bischoff","year":"2001","unstructured":"Bischoff E, Schneider K (2001) A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection. Int J Impot Res 13:230\u2013235","journal-title":"Int J Impot Res"},{"issue":"12","key":"22_CR20_22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.CIR.0000142209.28862.12","volume":"110","author":"E Bischoff","year":"2004","unstructured":"Bischoff E, Stasch JP (2004) Effects of the sGC stimulator BAY 41-2272 are not mediated by phosphodiesterase 5 inhibition. Circulation 110(12):320\u2013321","journal-title":"Circulation"},{"key":"22_CR21_22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0090-4295(02)02121-0","volume":"61","author":"E Bischoff","year":"2003","unstructured":"Bischoff E, Schramm M, Straub A, et al (2003) BAY 41-2272: a stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo. Urology 61:464\u2013467","journal-title":"Urology"},{"issue":"1","key":"22_CR22_22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.ijir.3901054","volume":"16","author":"TJ Bivalacqua","year":"2004","unstructured":"Bivalacqua TJ, Usta MF, Champion HC, et al (2004) Effect of combination endothelial nitric ox ide synthase gene therapy and sildenafil on erectile function in diabetic rats. Int J Impot Res 16(1):21\u201329","journal-title":"Int J Impot Res"},{"key":"22_CR23_22","first-page":"47","volume":"8","author":"M Boolell","year":"1996","unstructured":"Boolell M, Allen MJ, Ballard SA, et al (1996) Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 8:47\u201352","journal-title":"Int J Impot Res"},{"key":"22_CR24_22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.ijir.3900622","volume":"12","author":"M Braun","year":"2000","unstructured":"Braun M, Wassmer G, Klotz T, et al (2000) Epidemiology of erectile dysfunction: results of the \u2018Cologne Male Survey\u2019. Int J Impot Res 12:305\u2013311","journal-title":"Int J Impot Res"},{"issue":"5","key":"22_CR25_22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nm0597-571","volume":"3","author":"AL Burnett","year":"1997a","unstructured":"Burnett AL, Calvin DC, Chamness SL, et al (1997a) Urinary bladder-urethral sphincter dysfunc tion in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic void ing disorder in humans. Nature Med 3(5):571\u2013574","journal-title":"Nature Med"},{"issue":"1","key":"22_CR26_22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00005392-199707000-00020","volume":"158","author":"AL Burnett","year":"1997b","unstructured":"Burnett AL, Calvin DC, Silver RI, et al (1997b) Immunhistochemical description of nitric oxide synthase isoforms in human clitoris. J Urol 158(1):75\u201378","journal-title":"J Urol"},{"key":"22_CR27_22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.ijir.3901017","volume":"15","author":"DJ Carbone Jr","year":"2003","unstructured":"Carbone DJ Jr, Hodges S (2003) Medical therapy for benign prostatic hyperplasia: sexual dysfunc tion and impact on quality of life. Int J Impot Res 15:299\u2013306","journal-title":"Int J Impot Res"},{"issue":"suppl","key":"22_CR28_22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.amjcard.2005.07.010","volume":"96","author":"CC Carson","year":"2005","unstructured":"Carson CC (2005) cardiac safety in clinical trials of phosophodiesterase 5 inhibitors. Am J Cardiol 96(suppl):37\u201341","journal-title":"Am J Cardiol"},{"issue":"3","key":"22_CR29_22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1464-410X.2005.05614.x","volume":"96","author":"CC Carson","year":"2005","unstructured":"Carson CC, Lue TF (2005) Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int 96(3):257\u2013280","journal-title":"BJU Int"},{"issue":"6","key":"22_CR30_22","first-page":"623","volume":"108","author":"S Caruso","year":"2001","unstructured":"Caruso S, Intelisano G, Lupo L, et al (2001) Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. BJOG 108(6):623\u2013628","journal-title":"BJOG"},{"key":"22_CR31_22","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.fertnstert.2005.10.043","volume":"85","author":"S Caruso","year":"2006","unstructured":"Caruso S, Rugolo S, Agnello C, et al (2006) Sildenafil improves sexual functioning in pre menopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study. Fertil Steril 85:1496\u20131501","journal-title":"Fertil Steril"},{"key":"22_CR32_22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.eururo.2006.02.018","volume":"49","author":"CR Chapple","year":"2006","unstructured":"Chapple CR, Roehrborn CG (2006) A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol 49: 651\u2013659","journal-title":"Eur Urol"},{"key":"22_CR33_22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2005.02.024","volume":"48","author":"C Chapple","year":"2005","unstructured":"Chapple C, Khullar V, Gabriel Z, et al (2005) The effects of antimuscarinic treatments inoveractive bladder: a systematic review and meta-analysis. Eur Urol 48:5\u201326","journal-title":"Eur Urol"},{"key":"22_CR34_22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1464-410x.1999.00906.x","volume":"83","author":"J Chen","year":"1999","unstructured":"Chen J, Wollman Y, Chernichovsky T, et al (1999) Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled stud. BJU Int 83:269\u2013271","journal-title":"BJU Int"},{"issue":"4","key":"22_CR35_22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.ijir.3900685","volume":"13","author":"KK Chen","year":"2001","unstructured":"Chen KK, Hsieh JT, Huang ST, et al (2001) ASSESS-3: a randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan. Int J Impot Res 13(4):221\u2013229","journal-title":"Int J Impot Res"},{"issue":"8","key":"22_CR36_22","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s11095-006-9007-4","volume":"23","author":"L Claret","year":"2006","unstructured":"Claret L, Cox EH, McFadyen L, et al (2006) Modeling and simulation of sexual activity daily diary data of patients with female sexual arousal disorder treated with sildenafil citrate (Viagra\u00ae). Pharm Res 23(8):1756\u20131764","journal-title":"Pharm Res"},{"issue":"2","key":"22_CR37_22","doi-asserted-by":"crossref","first-page":"F357","DOI":"10.1152\/ajprenal.00261.2005","volume":"290","author":"W Conners","year":"2006","unstructured":"Conners W, Whitebeck C, Chicester P, et al (2006) L-NAME, a nitric oxide synthase inhibitor, diminishes oxidative damage in urinary bladder partial outlet obstruction. Am J Physiol Renal Physiol 290(2):F357\u2013F363","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"22_CR38_22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0898-6568(03)00134-7","volume":"16","author":"AL Cook","year":"2004","unstructured":"Cook AL, Haynes JM (2004) Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells. Cell Signal 16(2):253\u2013261","journal-title":"Cell Signal"},{"issue":"1","key":"22_CR39_22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.niox.2006.09.003","volume":"16","author":"AL Cook","year":"2007","unstructured":"Cook AL, Haynes JM (2007) Phosphorylation of the PKG substrate, vasodilator-stimulated phos phoprotein (VASP), in human cultured prostatic stromal cells. Nitric Oxide 16(1):10\u201317","journal-title":"Nitric Oxide"},{"key":"22_CR40_22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.ijir.3901215","volume":"216","author":"IS De Tejada","year":"2004","unstructured":"De Tejada IS (2004) Therapeutic strategies for optimizing PDE5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat. Int J Impot Res 216:40\u201342","journal-title":"Int J Impot Res"},{"issue":"2","key":"22_CR41_22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.ijir.3901490","volume":"19","author":"ME Dunn","year":"2007","unstructured":"Dunn ME, Althof SE, Perelman MA (2007) Phosphodiesterase type 5 inhibitors' extended duration of response as a variable in the treatment of erectile dysfunction. Int J Impot Res 19(2):119\u2013123","journal-title":"Int J Impot Res"},{"issue":"4","key":"22_CR42_22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2337\/diacare.25.4.672","volume":"25","author":"P Enzlin","year":"2002","unstructured":"Enzlin P, Mathieu C, Van den Bruel A, et al (2002) Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care 25(4):672\u2013677","journal-title":"Diabetes Care"},{"key":"22_CR43_22","unstructured":"Esteve SA Laboratorios (2004) WO2004026309"},{"issue":"9","key":"22_CR44_22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","volume":"5","author":"OV Evgenov","year":"2006","unstructured":"Evgenov OV, Pacher P, Schmidt PM, et al (2006) NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 5(9): 755\u2013768","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"22_CR45_22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.urology.2006.05.011","volume":"68","author":"MG Ferrini","year":"2006a","unstructured":"Ferrini MG, Davila HH, Kovanecz I, et al (2006a) Vardenafil prevents fibrosis and loss of cor poral smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology 68(2):429\u2013435","journal-title":"Urology"},{"issue":"3","key":"22_CR46_22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1464-410X.2006.05955.x","volume":"97","author":"MG Ferrini","year":"2006b","unstructured":"Ferrini MG, Kovanecz I, Nolazco G, et al (2006b) Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease. BJU Int 97(3):625\u2013633","journal-title":"BJU Int"},{"issue":"3","key":"22_CR47_22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/niox.2001.0421","volume":"6","author":"MG Ferrini","year":"2002","unstructured":"Ferrini MG, Vernet D, Magee TR, Shahed A, Qian A, Rajfer J, Gonzalez-Cadavid NF (2002) Antifibrotic role of inducible nitric oxide synthase. Nitric oxide May; 6(3):283\u201394","journal-title":"Nitric oxide May"},{"issue":"3","key":"22_CR48_22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/en.2006-1079","volume":"148","author":"S Filippi","year":"2007","unstructured":"Filippi S, Morelli A, Sandner P, et al (2007) Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology 148(3):1019\u20131029","journal-title":"Endocrinology"},{"key":"22_CR49_22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ucl.2005.08.001","volume":"32","author":"SH Francis","year":"2005","unstructured":"Francis SH, Corbin JD (2005) Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction. Urol Clin N Am 32:419\u2013429","journal-title":"Urol Clin N Am"},{"issue":"6","key":"22_CR50_22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1124\/mol.54.6.962","volume":"54","author":"A Friebe","year":"1998","unstructured":"Friebe A, M\u00fcllershausen F, Smolenski A, et al (1998) YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets. Mol Pharmacol 54(6):962\u2013967","journal-title":"Mol Pharmacol"},{"issue":"4","key":"22_CR51_22","first-page":"311","volume":"3","author":"Q Fu","year":"2001","unstructured":"Fu Q, Yao DH, Jiang YQ (2001) Effect of sodium nitroprusside on hemodynamics of corpus cav ernosum in Chinese. Asian J Androl 3(4):311\u2013313","journal-title":"Asian J Androl"},{"issue":"5","key":"22_CR52_22","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.juro.2007.07.048","volume":"178","author":"M Gacci","year":"2007","unstructured":"Gacci M, Del Popolo G, Macchiarella A, et al (2007) Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study. J Urol 178(5):2040\u20132043","journal-title":"J Urol"},{"issue":"4","key":"22_CR53_22","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1095\/biolreprod56.4.954","volume":"56","author":"H Garb\u00e1n","year":"1997","unstructured":"Garb\u00e1n H, Marquez D, Magee T, et al (1997) Cloning of rat and human inducible penile nitric oxide synthase. Application for gene therapy of erectile dysfunction. Biol Reprod 56(4):954\u2013963","journal-title":"Biol Reprod"},{"key":"22_CR54_22","first-page":"63","volume":"167","author":"E Gbekor","year":"2002","unstructured":"Gbekor E, Bethell S, Fawcett L, et al (2002) Selectivity of sildenafil and other phosphodiesterase type 5 (PDE5) inhibitors against all human phosphodiesterase families. J Urol 167:63","journal-title":"J Urol"},{"key":"22_CR55_22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1464-410X.2003.04727.x","volume":"93","author":"JI Gillespie","year":"2004","unstructured":"Gillespie JI, Drake MJ (2004) The actions of sodium nitropursside and the phosphdiesterase in hibior dipyridamole on phasic activity in the isolated guinea-pig bladder. BJU Int 93:851\u2013858","journal-title":"BJU Int"},{"key":"22_CR56_22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00441-005-0146-4","volume":"325","author":"JI Gillespie","year":"2006","unstructured":"Gillespie JI, Markerink\u2014van Ittersum M, De Vente J (2006) Endogenous nitric oxide\/cGMP sig nalling in the guinea pig bladder: evidence for distinct population of usub-urothelial interstitial cells. Cell Tissue Res 325:325\u2013332","journal-title":"Cell Tissue Res"},{"key":"22_CR57_22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0302-2838(03)00377-4","volume":"44","author":"F Giuliano","year":"2003","unstructured":"Giuliano F, Bernabe J, Alexandre L, et al (2003) Proerectile effect of vardenafil: in vitro experi ments in rabbits and in vivo comparison with sildenafil in rats. Eur Urol 44:731\u2013736","journal-title":"Eur Urol"},{"key":"22_CR58_22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.ju.0000071478.69480.fd","volume":"170","author":"ML Gonzalgo","year":"2003","unstructured":"Gonzalgo ML, Brotzman M, Trock BJ, et al (2003) Clinical efficacy of sildenafil citrate and pre dictors of long-term response. J Urol 170:503\u2013506","journal-title":"J Urol"},{"issue":"2","key":"22_CR59_22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<224::AID-PATH422>3.0.CO;2-K","volume":"189","author":"R Gradini","year":"1999","unstructured":"Gradini R, Realacci M, Ginepri A, et al (1999) Nitric oxide synthases in normal and benign hyperplastic human prostate: immunohistochemistry and molecular biology. J Pathol 189(2): 224\u2013229","journal-title":"J Pathol"},{"issue":"1","key":"22_CR60_22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00240-006-0073-1","volume":"35","author":"C Gratzke","year":"2007","unstructured":"Gratzke C, Uckert S, Kedia G, et al (2007) In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach. Urol Res 35(1):49\u201354","journal-title":"Urol Res"},{"key":"22_CR61_22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0094-0143(21)00662-5","volume":"22","author":"HA Guess","year":"1995","unstructured":"Guess HA (1995) Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin N Am 22:247\u2013261","journal-title":"Urol Clin N Am"},{"issue":"3","key":"22_CR62_22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1124\/mol.53.3.467","volume":"53","author":"JH Guh","year":"1998","unstructured":"Guh JH, Hwang TL, Ko FN, et al (1998) Antiproliferative effect in human prostatic smooth muscle cells by nitric oxide donor. Mol Pharmacol 53(3):467\u2013474","journal-title":"Mol Pharmacol"},{"issue":"11","key":"22_CR63_22","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1742-1241.2007.01560.x","volume":"61","author":"D Hatzichristou","year":"2007","unstructured":"Hatzichristou D, Haro JM, Martin-Morales A, et al (2007) Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the erectile dysfunction observational study. Int J Clin Pract 61(11):1850\u20131862","journal-title":"Int J Clin Pract"},{"issue":"1","key":"22_CR64_22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2006.07.020","volume":"51","author":"K Hatzimouratidis","year":"2007","unstructured":"Hatzimouratidis K, Hatzichristou D (2007) Phosphodiesterase type 5 inhibitors: the day after. Eur Urol 51(1):75\u201388","journal-title":"Eur Urol"},{"issue":"3","key":"22_CR65_22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0165-1838(96)00139-7","volume":"63","author":"P Hedlund","year":"1997","unstructured":"Hedlund P, Ekstr\u00f6m P, Larsson B, et al (1997) Heme oxygenase and NO-synthase in the human prostate-relation to adrenergic, cholinergic and peptide-containing nerves. J Auton Nerv Syst 63(3):115\u2013126","journal-title":"J Auton Nerv Syst"},{"issue":"4","key":"22_CR66_22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1743-6109.2006.00309.x","volume":"3","author":"WJ Hellstrom","year":"2006","unstructured":"Hellstrom WJ (2006) Current and future pharmacotherapies of preature ejaculation. J Sex Med 3(Suppl 4):332\u2013341","journal-title":"J Sex Med"},{"key":"22_CR67_22","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1742-1241.2007.01482.x","volume":"61","author":"WJ Hellstrom","year":"2007","unstructured":"Hellstrom WJ (2007) Current safety and tolerability issues in men with erectile dysfunction receiv ing PDE5 inhibitors. Int J Clin Pract 61:1547\u20131554","journal-title":"Int J Clin Pract"},{"issue":"6","key":"22_CR68_22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/j.1939-4640.2002.tb02332.x","volume":"23","author":"WJ Hellstrom","year":"2002","unstructured":"Hellstrom WJ, Gittelman M, Karlin G, et al (2002) Vardenafil for treatment of men with erec tile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 23(6):763\u2013771","journal-title":"J Androl"},{"issue":"1","key":"22_CR69_22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0304-3940(94)11275-N","volume":"186","author":"M Hern\u00e1ndez","year":"1995","unstructured":"Hern\u00e1ndez M, Prieto D, Orensanz LM, et al (1995) Nitric oxide is involved in the non-adrenergic, non-cholinergic inhibitory neurotransmission of the pig intravesical ureter. Neurosci Lett 186(1):33\u201336","journal-title":"Neurosci Lett"},{"key":"22_CR70_22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0090-4295(02)01534-0","volume":"59","author":"O Heuer","year":"2002","unstructured":"Heuer O, Ueckert S, Machtens SA, et al (2002) Effects of various nitric oxide donating agents on the contractility and cyclic nucleotide turnover of human seminal vesicles in vitro. Urology 59:958\u2013962","journal-title":"Urology"},{"key":"22_CR71_22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/phrs.1996.0022","volume":"33","author":"JP Hieble","year":"1996","unstructured":"Hieble JP, Ruffolo RR (1996) The use of alpha-adrenoceptor antagonists in the pharmacological management of benign prostatic hypertrophy: an overview. Pharmacol Res 33:145\u2013160","journal-title":"Pharmacol Res"},{"key":"22_CR72_22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1748-1716.1991.tb09236.x","volume":"143","author":"F Holmquist","year":"1991","unstructured":"Holmquist F, Stief CG, Jonas U, et al (1991) Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit. Acta Physiol Scand 143:299\u2013304","journal-title":"Acta Physiol Scand"},{"issue":"2","key":"22_CR73_22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0022-5347(01)66517-0","volume":"155","author":"CE Iselin","year":"1996","unstructured":"Iselin CE, Alm P, Schaad NC, et al (1996) Nitric oxide inhibits contraction of isolated pig ureteral smooth muscle. J Urol 155(2):763\u2013767","journal-title":"J Urol"},{"issue":"3","key":"22_CR74_22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1520-6777(1997)16:3<209::AID-NAU10>3.0.CO;2-G","volume":"16","author":"CE Iselin","year":"1997","unstructured":"Iselin CE, Alm P, Schaad NC, et al (1997) Localization of nitric oxide synthase and haemoxyge nase, and functional effects of nitric oxide and carbon monoxide in the pig and human intrav esical ureter. Neurourol 16(3):209\u2013227","journal-title":"Neurourol"},{"key":"22_CR75_22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archfami.2.7.729","volume":"2","author":"SJ Jacobsen","year":"1993","unstructured":"Jacobsen SJ, Guess HA, Panser L, et al (1993) A population-based study of health care-seeking behavior for treatment of urinary symptoms. Arch Fam Med 2:729\u2013735","journal-title":"Arch Fam Med"},{"issue":"2","key":"22_CR76_22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-5347(05)64009-8","volume":"169","author":"JS Kalsi","year":"2003","unstructured":"Kalsi JS, Rees RW, Hobbs AJ, et al (2003) BAY41-2272, a novel nitric oxide independent solu ble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro. J Urol 169(2):761\u2013766","journal-title":"J Urol"},{"issue":"6","key":"22_CR77_22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/sj.ijir.3901224","volume":"16","author":"JS Kalsi","year":"2004","unstructured":"Kalsi JS, Ralph DJ, Madge DJ, et al (2004) A comparative study of sildenafil, NCX-911 and BAY41-2272 on the anococcygeus muscle of diabetic rats. Int J Impot Res 16(6):479\u2013485","journal-title":"Int J Impot Res"},{"issue":"1","key":"22_CR78_22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1743-6109.2005.20105.x","volume":"2","author":"JS Kalsi","year":"2005","unstructured":"Kalsi JS, Ralph DJ, Thomas P, et al (2005) A nitric oxide-releasing PDE5 inhibitor relaxes human corpus cavernosum in the absence of endogenous nitric oxide. J Sex Med 2(1):53\u201357","journal-title":"J Sex Med"},{"issue":"2","key":"22_CR79_22","first-page":"73","volume":"9","author":"SA Kaplan","year":"2007","unstructured":"Kaplan SA, Gonzalez RR (2007) Phosphodiesterase type 5 inhibitors for the treatment of male lower urinary tract symptoms. Rev Urol 9(2):73\u201377","journal-title":"Rev Urol"},{"key":"22_CR80_22","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.2741\/1733","volume":"10","author":"M Kendirci","year":"2005","unstructured":"Kendirci M, Gur S, Sikka SC (2005) Gene therapy for erectile dysfunction. Front Biosci 10: 2758\u20132769","journal-title":"Front Biosci"},{"issue":"1","key":"22_CR81_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000064826","volume":"65","author":"MA Khan","year":"2000","unstructured":"Khan MA, Thompson CS, Mumtaz FH, et al (2000) Urological aspects of female sexual dysfunc tion. Urol Int 65(1):1\u20138","journal-title":"Urol Int"},{"issue":"3","key":"22_CR82_22","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/01.ju.0000109868.19569.d7","volume":"171","author":"SW Kim","year":"2004","unstructured":"Kim SW, Jeong SJ, Munarriz R, et al (2004) An in vivo rat model to investigate female vaginal arousal response. J Urol 171(3):1357\u20131361","journal-title":"J Urol"},{"issue":"12","key":"22_CR83_22","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V84.12.4226.bloodjournal84124226","volume":"84","author":"FN Ko","year":"1994","unstructured":"Ko FN, Wu CC, Kuo SC, et al (1994) YC-1, a novel activator of platelet guanylate cyclase. Blood 84(12):4226\u20134233","journal-title":"Blood"},{"issue":"2","key":"22_CR84_22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjcard.2005.03.065","volume":"96","author":"JB Kostis","year":"2005","unstructured":"Kostis JB, Jackson G, Rosen R, et al (2005) Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 96(2):313\u2013321","journal-title":"Am J Cardiol"},{"key":"22_CR85_22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0031-9384(99)00100-6","volume":"67","author":"LJ Kriegsfeld","year":"1999","unstructured":"Kriegsfeld LJ, Demas GE, Huang PL, et al (1999) Ejaculatory abnormalities in mice lacking the gene for endothelia nitric oxide synthase (eNOS-\/-). Physiol Behav 67:561\u2013566","journal-title":"Physiol Behav"},{"issue":"10","key":"22_CR86_22","first-page":"1051","volume":"52","author":"R Kuciel","year":"1970","unstructured":"Kuciel R, Ostrowski W (1970) Phosphodiesterase from human prostate gland. Bull Soc Chim Biol (Paris) 52(10):1051\u20131060","journal-title":"Bull Soc Chim Biol (Paris)"},{"issue":"2","key":"22_CR87_22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s002400050147","volume":"28","author":"R K\u00fchn","year":"2000","unstructured":"K\u00fchn R, Uckert S, Stief CG, et al (2000) Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways. Urol Res. 28(2):110\u2013115","journal-title":"Urol Res."},{"issue":"2","key":"22_CR88_22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ijir.3901533","volume":"19","author":"R Kukreja","year":"2007","unstructured":"Kukreja R, Salloum F, Xi L (2007) Anti-ischemic effects of sildenafil, vardenafil and tadalafil in heart. Int J Impot Res 19(2):226\u2013227","journal-title":"Int J Impot Res"},{"issue":"5","key":"22_CR89_22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1469-8986.1995.tb02095.x","volume":"32","author":"E Laan","year":"1995","unstructured":"Laan E, Everaerd W, van der Velde J, et al (1995) Determinants of subjective experience of sexual arousal in women: feedback from genital arousal and erotic stimulus content. Psychophysiol ogy 32(5):444\u2013451","journal-title":"Psychophysiol ogy"},{"key":"22_CR90_22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1743-6109.2006.00340.x","volume":"4","author":"EO Laumann","year":"2007","unstructured":"Laumann EO, West S, Glasser D, et al (2007) Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: from the male attitudes regarding sexual health survey. J Sex Med 4:57\u201365","journal-title":"J Sex Med"},{"issue":"1","key":"22_CR91_22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-1119(98)00303-5","volume":"216","author":"K Loughney","year":"1998","unstructured":"Loughney K, Hill TR, Florio VA, et al (1998) Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3\u2032,5\u2032-cyclic nucleotide phosphodiesterase. Gene 216(1):139\u2013147","journal-title":"Gene"},{"key":"22_CR92_22","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","volume":"342","author":"TF Lue","year":"2000","unstructured":"Lue TF (2000) Erectile dysfunction. New Eng J Med 342:1802\u20131813","journal-title":"New Eng J Med"},{"key":"22_CR93_22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0090-4295(02)02165-9","volume":"61","author":"S Machtens","year":"2002","unstructured":"Machtens S, Ueckert S, Stief CG (2002) Effects of various nitric oxide-donating drugs on adrener gic tension of human seminal vesicles in vitro. Urology 61:479\u2013483","journal-title":"Urology"},{"issue":"3","key":"22_CR94_22","first-page":"1033","volume":"67","author":"TR Magee","year":"2002","unstructured":"Magee TR, Ferrini M, Garban HJ, et al (2002) Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biol Reprod 67(3):1033\u20131041","journal-title":"Biol Reprod"},{"key":"22_CR95_22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/molehr\/gah143","volume":"11","author":"R Mancina","year":"2005","unstructured":"Mancina R, Filippi S, Marini M, et al (2005) Expression and functional activity of phosphodi esterase type 5 in human and rabbit vas deferens. Mol Hum Reprod 11:107\u2013115","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"22_CR96_22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2265.2006.02454.x","volume":"64","author":"V Martina","year":"2006","unstructured":"Martina V, Benso A, Gigliardi VR, et al (2006) Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects. Clin Endocrinol (Oxf) 64(3): 260\u2013264","journal-title":"Clin Endocrinol (Oxf)"},{"key":"22_CR97_22","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/01.ju.0000083492.80217.20","volume":"170","author":"D Mastrangelo","year":"2003","unstructured":"Mastrangelo D, Baertschi AJ, Roatti A, et al (2003) Nitric oxide production within rat urothelial cells. J Urol 170:1409\u20131414","journal-title":"J Urol"},{"issue":"suppl","key":"22_CR98_22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0022-5347(18)31568-4","volume":"177","author":"S Matsumoto","year":"2007","unstructured":"Matsumoto S, Watanabe E, Nakata Y, et al (2007) Bladder protective effects of PDE5 inhibitor: efficacy of vardenafil on rat bladder with outlet obstruction. J Urol 177(suppl):446","journal-title":"J Urol"},{"issue":"3","key":"22_CR99_22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1743-6109.2005.20351.x","volume":"2","author":"CG McMahon","year":"2005","unstructured":"McMahon CG, Stuckey BGA, Andersen M, et al (2005) Efficacy of sildenafil citrate (Viagra\u00ae) in men with premature ejaculation. J Sex Med 2(3):368\u2013375","journal-title":"J Sex Med"},{"key":"22_CR100_22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1464-410X.2006.06290.x","volume":"98","author":"CG McMahon","year":"2006","unstructured":"McMahon CG, McMahon CN, Leow LJ, et al (2006) Efficacy of type 5 phosphodiesterase in hibitors in the drug treatment of premature ejaculation: a systematic review. BJU 98:259\u2013272","journal-title":"BJU"},{"key":"22_CR101_22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0149-2918(07)80077-4","volume":"29","author":"KT McVary","year":"2007","unstructured":"McVary KT (2007) A review of combination therapy in patients with benign prostatic hyperplasia. Clin Ther 29:387\u2013398","journal-title":"Clin Ther"},{"issue":"3","key":"22_CR102_22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.juro.2006.10.055","volume":"177","author":"KT McVary","year":"2007a","unstructured":"McVary KT, Monnig W, Camps JL Jr, et al (2007a) Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms as sociated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 177(3): 1071\u20131077","journal-title":"J Urol"},{"issue":"4","key":"22_CR103_22","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.juro.2006.11.037","volume":"177","author":"KT McVary","year":"2007b","unstructured":"McVary KT, Roehrborn CG, Kaminetsky JC, et al (2007b) Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 177(4):1401\u20131407","journal-title":"J Urol"},{"issue":"3","key":"22_CR104_22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.ijir.3901522","volume":"19","author":"N Mehrotra","year":"2007","unstructured":"Mehrotra N, Gupta M, Kovar A, et al (2007) The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy. Int J Impot Res 19(3):253\u2013264","journal-title":"Int J Impot Res"},{"key":"22_CR105_22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-5347(01)62045-7","volume":"161","author":"A Melman","year":"1999","unstructured":"Melman A, Gingel AC (1999) The epidemiology and pathophysiology of erectile dysfunction. J Urol 161:5\u201311","journal-title":"J Urol"},{"issue":"9","key":"22_CR106_22","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0024-3205(02)02361-5","volume":"72","author":"LN Miller","year":"2003","unstructured":"Miller LN, Nakane M, Hsieh GC, et al (2003) A-350619: a novel activator of soluble guanylyl cyclase. Life Sci 72(9):1015\u20131025","journal-title":"Life Sci"},{"key":"22_CR107_22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","volume":"87","author":"I Milsom","year":"2001","unstructured":"Milsom I, Abrams P, Cardozo L, et al (2001) How widespread are the symptoms of the overactive bladder and how are they managed? A population based prevalence study. BJU Int 87:760\u2013766","journal-title":"BJU Int"},{"issue":"5","key":"22_CR108_22","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/S0022-5347(05)65142-7","volume":"167","author":"H Mizusawa","year":"2002","unstructured":"Mizusawa H, Hedlund P, Brioni JD, et al (2002) Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile response in rat. J Urol 167(5):2276\u20132281","journal-title":"J Urol"},{"key":"22_CR109_22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.ju.0000132159.61156.ea","volume":"172","author":"DK Montague","year":"2004","unstructured":"Montague DK, Jarow J, Broderick GA, et al (2004) AUA guideline on the pharmacologic manage ment of preature ejaculation. J Urol 172:290\u2013294","journal-title":"J Urol"},{"key":"22_CR110_22","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","volume":"171","author":"JP Mulhall","year":"2004","unstructured":"Mulhall JP, Creech SD, Boorjian SA, et al (2004) Subjective and objective analysis of the preva lence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 171:2350\u20132353","journal-title":"J Urol"},{"key":"22_CR111_22","first-page":"150","volume":"3","author":"K Murray","year":"1993","unstructured":"Murray K (1993) Phosphodiesterase 5 inhibitors. Drugs News Perspect 3:150\u2013156","journal-title":"Drugs News Perspect"},{"key":"22_CR112_22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(97)01270-3","volume":"337","author":"AT Najbar-Kaszkiel","year":"1997","unstructured":"Najbar-Kaszkiel AT, Di Iulio JL, Li CG, et al (1997) Characterisation of excitatory and inhibitory transmitter systems in prostate glands of rats, guinea pigs, rabbits and pigs. Eur J Pharmacol 337:251\u2013258","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"22_CR113_22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.urology.2005.11.055","volume":"67","author":"M Oelke","year":"2006","unstructured":"Oelke M, Hedlund P, Albrecht K, et al (2006) Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study. Urology 67(5):1111\u20131116","journal-title":"Urology"},{"issue":"3","key":"22_CR114_22","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1006\/bbrc.1998.9206","volume":"249","author":"K Park","year":"1998","unstructured":"Park K, Moreland RB, Goldstein I, et al (1998) Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Biochem Biophys Res Commun 249(3):612","journal-title":"Biochem Biophys Res Commun"},{"key":"22_CR115_22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1476-5381.1992.tb14483.x","volume":"107","author":"K Persson","year":"1992","unstructured":"Persson K, Igawa Y, Mattiasson A, et al (1992) Effects of inhibition of the L-arginine\/nitric oxide pathway in the rat lower urinary tract in vivo and in vitro. Br J Pharmacol 107:178\u2013184","journal-title":"Br J Pharmacol"},{"key":"22_CR116_22","first-page":"192","volume":"76","author":"G Piediferro","year":"2004","unstructured":"Piediferro G, Colpi EM, Castiglioni F, et al (2004) Preamture ejaculation 3d therapy. Arch Ital Uro Andro 76:192\u2013198","journal-title":"Arch Ital Uro Andro"},{"key":"22_CR117_22","first-page":"5","volume":"121","author":"H Porst","year":"2003","unstructured":"Porst H, Padma-Nathan H, Giuliano F, et al (2003) Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology 121:5","journal-title":"Urology"},{"issue":"1","key":"22_CR118_22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1743-6109.2004.10116.x","volume":"1","author":"J Pryor","year":"2004","unstructured":"Pryor J, Akkus E, Alter G, et al (2004) Peyronie's disease. J Sex Med 1(1):110\u2013115","journal-title":"J Sex Med"},{"issue":"6","key":"22_CR119_22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00240-001-0221-6","volume":"29","author":"Y Qiu","year":"2001","unstructured":"Qiu Y, Kraft P, Craig EC, et al (2001) Identification and functional study of phosphodiesterases in rat urinary bladder. Urol Res 29(6):388\u2013392","journal-title":"Urol Res"},{"issue":"1","key":"22_CR120_22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0090-4295(01)01471-6","volume":"59","author":"Y Qiu","year":"2002","unstructured":"Qiu Y, Kraft P, Craig EC, et al (2002) Cyclic nucleotide phosphodiesterases in rabbit detrusor smooth muscle. Urology 59(1):145\u2013149","journal-title":"Urology"},{"key":"22_CR121_22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1098-3597(05)80048-1","volume":"7","author":"A Rashid","year":"2005","unstructured":"Rashid A (2005) The efficacy and safety of PDE5 inhibitors. Clin Cornerstone 7:47\u201356","journal-title":"Clin Cornerstone"},{"key":"22_CR122_22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJM199201093260203","volume":"326","author":"J Rajfer","year":"1992","unstructured":"Rajfer J, Aronson WJ, Bush PA, et al (1992) Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 326:90\u201394","journal-title":"N Engl J Med"},{"key":"22_CR123_22","first-page":"29","volume":"5","author":"CG Roehrborn","year":"2002","unstructured":"Roehrborn CG (2002) Reducing the risk of benign prostatic hyperplasia progression. Rev Urol 5:29\u201338","journal-title":"Rev Urol"},{"issue":"2","key":"22_CR124_22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1742-1241.2001.tb10992.x","volume":"55","author":"R Sadovsky","year":"2001","unstructured":"Sadovsky R, Miller T, Moskowitz M, et al (2001) Three-year update of sildenafil citrate (Viagra\u00ae) efficacy and safety. Int J Clin Pract 55(2):115\u2013128","journal-title":"Int J Clin Pract"},{"key":"22_CR125_22","doi-asserted-by":"crossref","first-page":"509S","DOI":"10.1517\/14656566.7.5.509","volume":"7","author":"A Sahai","year":"2006b","unstructured":"Sahai A, Khan MS, Arya M, et al (2006b) The overactive bladder: review of current pharmacother apy in adults. Part 1: Pathophysiology and anticholinergic therapy. Expert Opin Pharmacother 7:509\u2013527S","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"22_CR126_22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.ijir.3901577","volume":"19","author":"P Sandner","year":"2007","unstructured":"Sandner P, H\u00fctter J, Tinel H, et al (2007) PDE5 inhibitors beyond erectile dysfunction. Int J Impot Res 19(6):533\u2013543","journal-title":"Int J Impot Res"},{"issue":"1","key":"22_CR127_22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1439-0272.1999.tb01452.x","volume":"31","author":"D Schultheiss","year":"1999","unstructured":"Schultheiss D, Stief CG (1999) Physiology and pathophysiology of erection: consequences for present medical therapy of erectile dysfunction. Andrologia 31(Suppl 1):59\u201364","journal-title":"Andrologia"},{"key":"22_CR128_22","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/265750a0","volume":"265","author":"KD Schultz","year":"1977","unstructured":"Schultz KD, Schultz K, Schultz G (1977) Sodium nitroprusside and other smooth muscle relaxants increase cGMP levels in rat ductus deferens. Nature 265:750\u2013751","journal-title":"Nature"},{"key":"22_CR129_22","unstructured":"Schwarz-Pharma AG ISIS-Pharma GmBH, (2000) WO2000010542"},{"issue":"2","key":"22_CR130_22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.ijir.3901491","volume":"19","author":"ER Schwarz","year":"2007","unstructured":"Schwarz ER, Kapur V, Rodriguez J, et al (2007) The effects of chronic phosphodiesterase-5 in hibitor use on different organ systems. Int J Impot Res 19(2):139\u2013148","journal-title":"Int J Impot Res"},{"issue":"4Suppl 1","key":"22_CR131_22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/clc.4960271305","volume":"27","author":"AD Seftel","year":"2004","unstructured":"Seftel AD (2004) Phosphodiesterase type 5 inhibitor differentiation based on selectivity, pharma cokinetic, and efficacy profiles. Clin Cardiol 27(4Suppl 1):14\u201319","journal-title":"Clin Cardiol"},{"issue":"5","key":"22_CR132_22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0302-2838(02)00397-4","volume":"42","author":"M Seidler","year":"2002","unstructured":"Seidler M, Uckert S, Waldkirch E, et al (2002) In vitro effects of a novel class of nitric oxide (NO) donating compounds on isolated human erectile tissue. Eur Urol 42(5):523\u2013528","journal-title":"Eur Urol"},{"key":"22_CR133_22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1743-6109.2005.00139.x","volume":"6","author":"R Shabsigh","year":"2005","unstructured":"Shabsigh R (2005) Testosterone therapy in erectile dysfunction and hypogonadism. J Sex Med (6):785\u2013792","journal-title":"J Sex Med"},{"issue":"2","key":"22_CR134_22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/01.ju.0000132389.97804.d7","volume":"172","author":"R Shabsigh","year":"2004","unstructured":"Shabsigh R, Kaufman JM, Steidle C, et al (2004) Randomized study of testosterone gel as adjunc tive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 172(2):658\u2013663","journal-title":"J Urol"},{"issue":"5","key":"22_CR135_22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.annemergmed.2007.05.015","volume":"50","author":"A Singh","year":"2007","unstructured":"Singh A, Alter HJ, Littlepage A (2007) A systematic review of medical therapy to facilitate passage of ureteral calculi. Ann Emerg Med 50(5):552\u2013563","journal-title":"Ann Emerg Med"},{"issue":"2","key":"22_CR136_22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/bbrc.1998.8769","volume":"247","author":"P Stacey","year":"1998","unstructured":"Stacey P, Rulten S, Dapling A, et al (1998) Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). Biochem Biophys Res Commun 247(2):249\u2013254","journal-title":"Biochem Biophys Res Commun"},{"key":"22_CR137_22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35065611","volume":"8","author":"JP Stasch","year":"2001","unstructured":"Stasch JP, Becker EM, Alonso-Alija C, et al (2001) NO-independent regulatory site on soluble guanylate cyclase. Nature 8:212\u2013215","journal-title":"Nature"},{"issue":"5","key":"22_CR138_22","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0022-5347(17)36931-8","volume":"148","author":"CG Stief","year":"1992","unstructured":"Stief CG, Holmquist F, Djamilian M, et al (1992) Preliminary results with the nitric oxide donor linsidomine chlorhydrate in the treatment of human erectile dysfunction. J Urol 148(5): 1437\u20131440","journal-title":"J Urol"},{"issue":"4","key":"22_CR139_22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000282783","volume":"55","author":"CG Stief","year":"1995","unstructured":"Stief CG, Taher A, Truss M, et al (1995) Phosphodiesterase isoenzymes in human ureteral smooth muscle: identification, characterization, and functional effects of various phosphodiesterase in hibitors in vitro. Urol Int 55(4):183\u2013189","journal-title":"Urol Int"},{"issue":"6","key":"22_CR140_22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00389789","volume":"24","author":"CG Stief","year":"1996","unstructured":"Stief CG, Uckert S, Truss MC, Becker AJ, et al (1996) A possible role for nitric oxide in the regulation of human ureteral smooth muscle tone in vitro. Urol Res 24(6):333\u2013337","journal-title":"Urol Res"},{"issue":"6","key":"22_CR141_22","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.eururo.2008.01.075","volume":"53","author":"CG Stief","year":"2008","unstructured":"Stief CG, Porst H, Neuser D, et al (2008) A randomised, placebo-controlled study to assess the efficacy of twice-daily Vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 53(6):1236\u20131244","journal-title":"Eur Urol"},{"issue":"6","key":"22_CR142_22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0960-894X(01)00073-7","volume":"11","author":"A Straub","year":"2001","unstructured":"Straub A, Stasch JP, Alonso-Alija C, et al (2001) NO-independent stimulators of soluble guanylate cyclase. Bioorg Med Chem Lett Mar 11(6):781\u2013784","journal-title":"Bioorg Med Chem Lett Mar"},{"issue":"2","key":"22_CR143_22","first-page":"11","volume":"4","author":"A Taher","year":"1992","unstructured":"Taher A, Stief C, Raida M, et al (1992) Cyclic nucleotide phosphodiesterase activity in hu man cavernous smooth muscle and the effect of various selective inhibitors. Int J Impot Res 4(Suppl2):11","journal-title":"Int J Impot Res"},{"issue":"5","key":"22_CR144_22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00191209","volume":"12","author":"A Taher","year":"1994","unstructured":"Taher A, Schulz-Knappe P, Meyer M, et al (1994) Characterization of cyclic nucleotide phos phodiesterase isoenzymes in the human ureter and their functional role in vitro. World J Urol 12(5):286\u2013291","journal-title":"World J Urol"},{"key":"22_CR145_22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF01275154","volume":"15","author":"A Taher","year":"1997","unstructured":"Taher A, Meyer M, Stief CG, et al (1997) Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle. World J Urol 15:32\u201335","journal-title":"World J Urol"},{"issue":"3","key":"22_CR146_22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0090-4295(99)80013-2","volume":"45","author":"M Takeda","year":"1995","unstructured":"Takeda M, Tang R, Shapiro E, et al (1995) Effects of nitric oxide on human and canine prostates. Urology 45(3):440\u2013446","journal-title":"Urology"},{"issue":"2","key":"22_CR147_22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","volume":"11","author":"E Takimoto","year":"2005","unstructured":"Takimoto E, Champion HC, Li M, et al (2005) Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 11(2):214\u2013222","journal-title":"Nat Med"},{"key":"22_CR148_22","first-page":"289","volume":"21","author":"S Tejada","year":"2004","unstructured":"Tejada S, Angulo J, Cellek S, et al (2004) Physiology of erectile function and pathophysiology of eretile dysfunction. Sexual medicine and sexual dysfunction in men and women. Editions 21:289\u2013343","journal-title":"Editions"},{"issue":"23","key":"22_CR149_22","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1001\/jama.294.23.2996","volume":"294","author":"IM Thompson","year":"2005","unstructured":"Thompson IM, Tangen CM, Goodman PJ, et al (2005) Erectile dysfunction and subsequent cardio vascular disease. JAMA 294 (23):2996\u20133002","journal-title":"JAMA"},{"key":"22_CR150_22","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(03)13073-5","volume":"361","author":"A Thorpe","year":"2003","unstructured":"Thorpe A, Neal D (2003) Benign prostatic hyperplasia. Lancet 361:1359\u20131367","journal-title":"Lancet"},{"issue":"2","key":"22_CR151_22","first-page":"72","volume":"5","author":"H Tinel","year":"2008","unstructured":"Tinel H, Sandner P (2008) Vardenafil enhances proceptive and receptive sexual behaviour in the female rat. J Sex Med 5(suppl2):72","journal-title":"J Sex Med"},{"issue":"5","key":"22_CR152_22","first-page":"399","volume":"3","author":"H Tinel","year":"2006a","unstructured":"Tinel H, Huetter J, Sandner P (2006a) PDE5 inhibitors relaxes isolated rat vaginal strips and rat clitoral corpus cavernousum. J Sex Med 3(suppl 5):399","journal-title":"J Sex Med"},{"issue":"6","key":"22_CR153_22","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1464-410X.2006.06501.x","volume":"98","author":"H Tinel","year":"2006b","unstructured":"Tinel H, Stelte-Ludwig B, H\u00fctter J, et al (2006b) Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms. BJU Int 98(6):1259\u20131263","journal-title":"BJU Int"},{"key":"22_CR154_22","doi-asserted-by":"crossref","first-page":"H419","DOI":"10.1152\/ajpcell.1993.264.2.C419","volume":"264","author":"F Trigo-Rocha","year":"1993","unstructured":"Trigo-Rocha F, Aronson WJ, Hohenfellner M, et al (1993) Nitric oxide and cGMP: mediators of pelvic nerve-stimulated erection in dogs. Am J Physiol 264:H419\u2013H422","journal-title":"Am J Physiol"},{"key":"22_CR155_22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00304074","volume":"24","author":"MC Truss","year":"1996a","unstructured":"Truss MC, \u00dcckert S, Stief CG, et al (1996a) Cyclic nucleotide phosphodiesterase (PDE) isoen-zymes in the human detrusor smooth muscle: I. Identification and characterisation. Urol Res 24:123\u2013128","journal-title":"Urol Res"},{"key":"22_CR156_22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00304074","volume":"24","author":"MC Truss","year":"1996b","unstructured":"Truss MC, \u00dcckert S, Stief CG, et al (1996b) Cyclic nucleotide phosphodiesterase (PDE) isoen-zymes in the human detrusor smooth muscle: II. Effect of various PDE-inhibitors on smooth muscle tone and cyclic nucleotide levels in vitro. Urol Res 24:123\u2013128","journal-title":"Urol Res"},{"issue":"6","key":"22_CR157_22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/PL00007088","volume":"18","author":"MC Truss","year":"2000","unstructured":"Truss MC, Stief CG, Uckert S, et al (2000) Initial clinical experience with the selective phosphodiesterase-I isoenzyme inhibitor vinpocetine in the treatment of urge incontinence and low compliance bladder. World J Urol 18(6):439\u2013443","journal-title":"World J Urol"},{"key":"22_CR158_22","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/S0022-5347(05)65621-2","volume":"166","author":"S Uckert","year":"2001","unstructured":"Uckert S, Kuthe A, Jonas U, et al (2001) Characterization and functional relevance of cyclic nu cleotide phosphodiesterase isoenzymes of the human prostate. J Urol 166:2484\u20132490","journal-title":"J Urol"},{"key":"22_CR159_22","first-page":"7","volume":"9","author":"St \u00dcckert","year":"2002","unstructured":"\u00dcckert St, Seemann C, Stief CG, et al (2002) Funktionelle in vitro-effekte cAMP\/cGMP mod uliernder Pharmaka am humanen Detrusormuskel. J. Urol Urogyn\u00e4kol 9:7\u201314","journal-title":"J. Urol Urogyn\u00e4kol"},{"issue":"3","key":"22_CR160_22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.urology.2004.10.028","volume":"65","author":"S Uckert","year":"2005a","unstructured":"Uckert S, Oelke M, Waldkirch E, et al (2005a) Cyclic adenosine monophosphate and cyclic guano sine monophosphate-phosphodiesterase isoenzymes in human vagina: relation to nitric ox ide synthase isoforms and vasoactive intestinal polypeptide-containing nerves. Urology 65(3): 604\u2013610","journal-title":"Urology"},{"issue":"6","key":"22_CR161_22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00345-005-0014-6","volume":"23","author":"S Uckert","year":"2005b","unstructured":"Uckert S, Ehlers V, Nuser V, et al (2005b) In vitro functional responses of isolated human vaginal tissue to selective phosphodiesterase inhibitors. World J Urol 23(6):398\u2013404","journal-title":"World J Urol"},{"key":"22_CR162_22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.eururo.2005.12.050","volume":"49","author":"S Uckert","year":"2006","unstructured":"Uckert S, Oelke M, Stief CG, et al (2006) Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate. Eur Urol 49:740\u2013745","journal-title":"Eur Urol"},{"issue":"6","key":"22_CR163_22","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/j.1743-6109.2007.00595.x","volume":"4","author":"S Uckert","year":"2007","unstructured":"Uckert S, Ellinghaus P, Albrecht K, et al (2007) Expression of messenger ribonucleic acid encoding for phosphodiesterase isoenzymes in human female genital tissues. J Sex Med 4(6):1604\u20131609","journal-title":"J Sex Med"},{"key":"22_CR164_22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.niox.2003.12.002","volume":"9","author":"EG Valente","year":"2003","unstructured":"Valente EG, Vernet D, Ferrini M, et al (2003) L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide 9:229\u2013244","journal-title":"Nitric Oxide"},{"issue":"4","key":"22_CR165_22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1089-8603(02)00124-6","volume":"7","author":"D Vernet","year":"2002","unstructured":"Vernet D, Ferrini MG, Valente EG, et al (2002) Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. Nitric Oxide 7(4):262\u2013276","journal-title":"Nitric Oxide"},{"issue":"2","key":"22_CR166_22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.eururo.2007.02.004","volume":"52","author":"ES Waldkirch","year":"2007","unstructured":"Waldkirch ES, Uckert S, Langn\u00e4se K, et al (2007) Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue. Eur Urol 52(2):495\u2013501","journal-title":"Eur Urol"},{"issue":"1","key":"22_CR167_22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1464-410X.2007.07182.x","volume":"101","author":"E Waldkirch","year":"2008","unstructured":"Waldkirch E, Uckert S, Schultheiss D, et al (2008) Non-genomic effects of androgens on isolated human vascular and nonvascular penile erectile tissue. BJU Int 101(1):71\u201375","journal-title":"BJU Int"},{"key":"22_CR168_22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2605.2006.00689.x","volume":"29","author":"WF Wang","year":"2006","unstructured":"Wang WF, Minhas S, Ralph DJ (2006) Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation. Intl J Androl 29:503\u2013509","journal-title":"Intl J Androl"},{"issue":"1","key":"22_CR169_22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200411-1587OC","volume":"172","author":"J Wharton","year":"2005","unstructured":"Wharton J, Strange JW, M\u00f8ller GM, et al (2005) Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. Am J Respir Crit Care Med 172(1):105\u2013113","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"22_CR170_22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1432-1327.1998.2550391.x","volume":"255","author":"N Yanaka","year":"1998","unstructured":"Yanaka N, Kotera J, Ohtsuka A (1998) Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene. Eur J Biochem 255(2):391\u2013399","journal-title":"Eur J Biochem"}],"container-title":["Handbook of Experimental Pharmacology","cGMP: Generators, Effectors and Therapeutic Implications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-68964-5_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T04:18:02Z","timestamp":1709785082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-68964-5_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540689607","9783540689645"],"references-count":170,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-68964-5_22","relation":{},"ISSN":["0171-2004"],"issn-type":[{"value":"0171-2004","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}